Global Health Leadership Forum
An International Program to Rethink
Health Policy and Health Systems Change
University of California's distinguished faculty is engaged in advanced research and is in constant dialogue with executives who are leading their industries. These activities ensure that you are immersed in the most critical and contemporary issues. Through this interaction, you'll learn to recognize the types of information and intuition that stimulate effective implementation of health care strategy and vision in organizations and countries. We are grateful to our guest speakers, well-known health care leaders who have agreed to join us in our quest to advance the state of knowledge regarding effective health care policies and management.
Molly Joel Coye, M.D., M.P.H.
- Founder and CEO, Health Technology Center (HealthTech)
Dr. Coye was an executive in the Good Samaritan Health System, a large nonprofit integrated health care system in California, and she also directed product development and marketing for HealthDesk Corporation, a developer of consumer software for interactive health communication and disease management. From 1991 to 1993, Dr. Coye was the director of the California Department of Health Services, managing a budget of more than $16 billion, 5,000 employees and 160 branch and field offices throughout the state.
Fluent in Spanish and Chinese, she has also served as a consultant with the World Health Organization and the Pan American Health Organization.
Sir Richard G. A. Feachem, K.B.E., B.Sc., F.R.Eng., Ph.D., D.Sc. (Med), F.I.C.
- First Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria
- Undersecretary General, United Nations
- Professor of International Health, University of California, San Francisco and the University of California, Berkeley
- Founding Director, Institute for Global Health, UCSF and UCB
Location: Institute for Global Health, 50 Beale St., Suite 1200, San Francisco, CA 94105
Websites: http://globalhealthsciences.ucsf.edu/igh
http://www.theglobalfund.org
Dr. Richard Feachem has worked in international health and development for 30 years and has published extensively on public health and health policy.
Dr. Feachem stepped down as the first Executive Director for the Global Fund to Fight AIDS, Tuberculosis and Malaria on March 31, 2007 after a five year term. Prior to his position at the Global Fund, Dr. Feachem was Director for Health, Nutrition and Population at the World Bank and Dean of the London School of Hygiene and Tropical Medicine.
Sir Richard was knighted by Her Majesty Queen Elizabeth II in 2007. He has also received honours from the Governments of Niger and Togo.
Neelam Sekhri Feachem, M.H.A.
- Chief Executive Officer, The Healthcare Redesign Group
Ms. Sekhri Feachem has over 25 years of experience in health financing, health systems, health financing and health management. Ms. Sekhri served as health financing and policy advisor at the World Health Organization until 2007, where she provided technical and policy guidance on health financing strategies with a particular focus on private and social insurance, and methods to complement public financing with private funding instruments.
As founder of The Healthcare Redesign Group Inc. in 1994, Ms. Sekhri Feachem heads a consultancy that has been recognized by the San Francisco Business Times as one of the fastest-growing privately-held companies in the San Francisco area. She advises government ministries, insurers, providers and international organizations on a health systems, health financing and health policy issues.
Prior to founding The Healthcare Redesign Group, Ms. Sekhri Feachem spent 14 years with Kaiser Permanente where she held executive positions in hospital and medical group management, organizational development, and finance.
Ms. Sekhri Feachem has served on various Boards including the Commercial Advisory Board of the British National Health Service, the Organization for Economic Development (OECD) Working Group for Private Insurance and the Board of the Alameda County Hospital system.
Pamela Garside, MHA
- Visiting faculty at Judge Business School, the business school of the University of Cambridge
- Co-Director of the Cambridge Programme of the Global Health Leadership Forum
- Owner of Newhealth, a management consultancy specialsing in organizational strategy and development in health care
- Chairman and CEO, Kaiser Permanente
- Chairman and CEO, Healthwise, a not-for-profit organization dedicated to helping people make better health decisions
- Founding Chair, IxCenter Board of Directors
- Medical Director, Pacific Business Group on Health (PBGH)
- National Health Care Thought Leader, William H. Mercer
- Senior Research Fellow and President Emeritus, Institute for the Future (IFTF)
- Health Advisory Panel Chair, Institute for the Future's Health Advisory Panel
- Founding Partner, Strategic Health Perspectives (SHP)
- Regional Advisor for Mental Health, WHO, Europe
- Deputy Editor for Global Health, Health Affairs Journal
- Adjunct Professor of International Relations, Johns Hopkins University
- Lead Economist for Health, Nutrition and Population for West Africa, World Bank: US$1.8 billion under active implementation and US$164 million in the pipeline
- Editor, World Bank's HNP Publication Series
- President, International Health Summit
- Vice-Chairman, Governance Institute
- Consultant, Larson Allen
- Medical Director for Health and Productivity Management Programs Kaiser Permanente
- Paul J. Cortese Distinguished Professor of Management
- Director, Haas School, Ph.D. Program
- Haas Organizational Behavior and Industrial Relations Group
- Professor of Health Economics
- Professor of Developmont Economics, University of California, Global Health, San Francisco
- The T. & G. Angelopoulos Visiting Professor of Public Health and International Development in the Kennedy School of Government and the School of Public Health, Harvard University
- Health Care Consultant
- Program Director, Global Health Leadership Forum
- Caldwell B. Esselstyn Professor of Health Policy and Health Economics
- Director, Institute for Health Policy Studies
- Henry J. Kaiser Professor of Organized Health Systems
- Distinguished Professor of Health Economics & Public Policy/Director, Petris Center & HPTP-RWJ
- Blue Cross of California, Distinguished Professor of Health Policy & Management
- Dean, School of Public Health
- Director, Advanced Health Leadership Forum
- President, Chairman, and CEO, Blue Shield of California
- Lecturer and Professor of Health Sciences, Department of Health Policy and Management, Ben-Gurion University of the Negev, Israel
- Research Associate, National Bureau of Economic Research, NYC
- Consultant, World Bank, Washington DC
- Visiting Senior Lecturer, Bar-Ilan University, Israel
- Professor of Public Policy
- Marriner S. Eccles Professor of Public and Private Management, Emeritus, Graduate School of Business, Stanford University
- Senior Fellow, Center for Health Policy, Institute of International Relations, Stanford University
- President, U.S. Institute of Medicine of The National Academies
- Professor Emeritus of Health Policy and Management, Department of Health Policy and Management
- President, Product Development, Genentech
- Adjunct Associate Professor, Epidemiology and Biostatistics, University of California, San Francisco
- Two-term Governor of Oregon, USA
- President and CEO of National Quality Forum
- Former CEO and Chairman of Board, Kaiser Foundation Health Plan
- Executive Director and CEO, The Permanente Medical Group, Northern California
- Professor of Health Policy & Management
- President, Gordon & Betty Moore Foundation
- Adjunct Professor and Executive Director, Graduate Program in Health Management
- Director, Health Policy Analysis and Research
- Kaiser Permanente Institute for Health Policy
- Kaiser Permanente Medical Care Program
- Professor of Health Economics
- Associate Director, Center for Health Workforce Studies
- Assistant Adjunct Professor, Community Health Systems, School of Nursing
- John M. Olin Senior Fellow, Project HOPE
- Co-chair, President’s Task Force to Improve Health Care Delivery for Our Nation’s Veterans
- Professor and Vice-Rector, Department of Economics and Business, Universitat Pompeu Fabra
- Director of the Master in Accounting and Financial Management, Continuing Education Institute (iDEC), Universitat Pompeu Fabra
- Director, Health System Policies and Operations, World Health Organization (WHO), Geneva, Swtizerland
- Professor, Department of Economics, Universidad Carlos III de Madrid
- Chairman, Department of International Health, Escuela Nacional de Sanidad (National School of Public Health); Instituto de Salud Carlos III
- Professor, Applied Economics, Department of Quantitative Methods, University of Las Palmas de Gran Canaria
- Associate Professor of Business, Department of Economics and Business, Universitat Pompeu Fabra
- President, Associacion de Economia de la Salud (Spanish Health Economics Association)
- Strategic Development Director, DKV Seguros (insurance company)
- Co-Director, Advanced Health Leadership Forum
- Board of Directors, Bank of Spain
- Professor of Applied Economics, Department of Economics and Business, Universitat Pompeu Fabra
- Assistant Professor of Economics, IESE Business School, Universidad de Navarra
- Faculty Coordinator, Advanced Health Leadership Forum
- Senior Lecturer of Economics and Business
- Director of CRES
- President of Spanish Health Economics Association
- Associate Professor of Health Politics, Institute of Health Management and Health Economics, University of Oslo, Norway
- Associate Professor of Political Science and Health Policy, Institute of Health Politics and Management, Erasmus University, The Netherlands
- Senior Lecturer in Economics, University of Barcelona
- Deputy Director, Welfare Economics Research Center, Centre de Recerca en Economia del Benestar (CREB)
- Senior Researcher, institute for Medical Technology Assessment (iMTA), Erasmus University Medical Center, The Netherlands
- Clinical and Public Health Director, National Institute for Health and Clinical Excellence (NICE)
Location:Newhealth, 24 Milson Road, London W14 OLJ, UK
Website: http://www.jbs.cam.ac.uk/research/associates/garsidep.html
Pam Garside has her own management consultancy, Newhealth, specialising in organisational strategy and development in health care. She is a member of the visiting faculty at Judge Business School, the business school of the University of Cambridge, where she is Co-Director of the Cambridge International Health Leadership Programme. She began her professional life in management in the NHS and subsequently spent ten years studying and working internationally based in the USA. Since the mid-1980s she has worked as a management adviser and consultant concentrating on the reform of healthcare systems, and leadership and management development.
Pam is a member of the board of Quality and Safety in Health Care, a BMJ publication, Chairman of the Board of Governors of the Royal College of Nursing's School of Higher Education, and a Board Director of the International Women's Forum Leadership Foundation in Washington DC. She is co-owner and Chairman of the International Health Summit, USA and a Senior Associate of the Nuffield Trust. She is also a member of the Organisational Analysis research group and the Human Resources & Organisations teaching group.
George C. Halvorson
Donald W. Kemper, M.P.H.
Mr. Kemper is a passionate advocate for improving patient-physician partnerships through prescription information. By offering every patient the right information prescription as part of the process of care, the health care system can achieve measurable improvements in medical outcomes, patient safety, the overall cost-effectiveness of care, and patient satisfaction.
Mr. Kemper co-authored Information Therapy: Prescribed Information as a Reimbursable Medical Service with Molly Mettler. The Ix® book lays out both the concept and the practical details of how information prescriptions will become a core and expected part of health care.
Arnold Milstein, M.D.
His work focuses on improving managed care programs for large purchasers and government. In October 2006 Dr. Milstein was elected to the Institute of Medicine. Since January 2002, Dr. Milstein has also served on the Strategic Advisory Council of the National Quality Forum (NQF).
Ian Morrison, M.A., Ph.D.
Dr. Ian Morrison is an internationally known author, consultant and speaker specializing in long-term forecasting and planning with particular emphasis on health care and the changing business environment.
Dr. Matthijs (Matt) Muijen, M.D.
Philip Musgrove, Ph.D.
Dr. Philip Musgrove has worked on health reform projects in Argentina, Brazil, Chile and Colombia, besides dealing with a variety of issues in health economics, financing, equity, nutrition, household income and consumption and natural resources.
From October 2002 to September 2005, Dr. Musgrove was an Editor of the Disease Control Priorities Project at the Fogarty International Center of the National Institutes of Health. He worked for the World Bank (1990-2002), retiring as a Principal Economist, having been Advisor in Health Economics, Pan American Health Organization (1982-1990) and a Research Associate at the Brookings Institution and at Resources for the Future (1964-1981).
Alexander S. Preker, M.D., Ph.D.
Dr. Alexander S. Preker is currently leading a team of technical experts that is preparing a report on the financial sustainability of reaching the Millennium Development Goals and fiscal space for health. In collaboration with UNICEF, the ILO and several bilateral donors he recently helped the WHO Regional Office in Brazzaville prepare a Health Financing Strategy for the Africa Region which was adobted by the 56th Regional Council of Health Ministers in August 2006.
James A. Rice, Ph.D.
Dr. James Rice is well known for his international leadership development work at Cambridge University's International Health Leadership Programme and as President of The International Health Summit. He has held executive positions at the Minneapolis-based Health One/Health Span System (now Allina, Inc.). Dr. Rice draws upon extensive experience in hospital and integrated system development, managed care, and HMOs.
Dr. Rice's 30 years of experience also includes important work as a teacher, author, speaker and consultant to physician groups, boards of directors and health sector leaders in over 30 countries. He also works in international health policy research and development, with a special focus on public health finance. He has received many distinguished awards, including the Corning Award for excellence in U.S. hospital planning. He is the co-founder and former president of the AHA Society for Hospital Planning and Marketing.
Leonard D. Schaeffer
Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint, the nation's largest health insurance company. WellPoint has over 34 million medical members and revenues of over $56 billion. He is currently Chairman of Surgical Care Affiliates and a Senior Advisor to TPG Capital, a private equity firm.
Mr. Schaeffer was Chairman & CEO of WellPoint from 1993 through 2004 and continued as Chairman through 2005. In 1986, Mr. Schaeffer was recruited as CEO of WellPoint's predecessor company, Blue Cross of California, when it was near bankruptcy. He managed the turnaround of Blue Cross, founded WellPoint and completed 17 acquisitions. During his tenure, the company grew in value from $11 million to over $49 billion. Under Mr. Schaeffer's leadership, WellPoint was selected by Fortune as America's Most Admired Health Care Company for six consecutive years and by BusinessWeek as one of the 50 best performing public companies for three consecutive years. Mr. Schaeffer was selected by BusinessWeek as one of the Top 25 Managers of the Year and by Worth as one of the "50 Best CEOs in America".
Mr. Schaeffer's public service included appointments as Administrator of the federal Health Care Financing Administration (now CMS), Assistant Secretary for Management and Budget of the federal Department of Health, Education and Welfare, Director of the Bureau of the Budget for the state of Illinois, Chairman of the Illinois Capital Development Board, and Deputy Director of the Illinois Department of Mental Health.
Mr. Schaeffer was also President & CEO of Group Health, Inc., EVP & COO of the Student Loan Marketing Association, (Sallie Mae) and a Vice President of Citibank.
Onno Schellekens, M.B.A.
Managing Director, PharmAccess
The Netherlands
PharmAccess Foundation is a Dutch not-for-profit organization supporting basic health care including HIV/AIDS treatment and care in Africa. Onno Schellekens is responsible for the day-to-day practices of the organization.
Mr. Schellekens is founder of the Health Insurance Fund and the Investment Fund for Health in Africa. The Health Insurance Fund (HIF), established in 2005, aims to introduce medical insurance schemes for low- and no-income groups through private healthcare providers. In 2006 the HIF received a grant of 100 million Euro from the Dutch government. In 2006 the HIF launched its first program in Nigeria. He also initiated the Investment Fund for Health in Africa in 2007 which was launched with support of three large banks and insurers, SNS Reaal, ACHMEA and AEGON. They provide investment capital for the fund.
Paul Wallace, M.D.
Paul Wallace, MD, has combined experiences in clinical medical oncology and hematology practice with work in quality improvement, especially in the areas of performance measurement, evidence based medicine and population based care. As in Kaiser Permanente’s national Permanente Federation, he has responsibilities for the development and analysis of clinical population-based wellness and health maintenance interventions.
Andrew M. Wiesenthal, M.D., S.M.
Andrew M. Wiesenthal, MD, SM is Associate Executive Director of the Permanente Federation for Clinical Information Support. From 1983 until April 2000, Dr. Wiesenthal served as a pediatrician and pediatric infectious disease consultant with the Colorado Permanente Medical Group (CPMG). He also led CPMG's quality management program and served as Associate Medical Director for Medical Management, with responsibility for quality management, utilization management, regulatory compliance, risk management, credentialing and physician performance, and informatics. His current work is in the arenas of development and deployment of automated medical records, decision support, and other clinical systems for all of Kaiser Permanente.
Dr. Wiesenthal graduated from Yale University with a BA degree with honors in Latin American Studies in 1971 and received his MD in 1975 from the State University of New York, Downstate Medical Center in Brooklyn. He completed his pediatric residency at the University of Colorado in 1978 and then served as an Epidemic Intelligence Service Officer with the Centers for Disease Control from 1978-80 before returning to the University of Colorado for a pediatric infectious disease fellowship, which was completed in 1983. In 2004, Dr. Wiesenthal earned an SM in Health Care Management from the Harvard School of Public Health.
FACULTY:
Jennifer Chatman, Ph.D.
Academic Group: http://www.haas.berkeley.edu/groups/obir/
Teh-wei Hu, Ph.D.
Dean Jamison, Ph.D.
Meg A. Kellogg
Hal Luft, Ph.D.
University of California San Francisco
Thomas Rundall, Ph.D.
Richard Scheffler, Ph.D.
Global Health Leadership Forum
Goldman School of Public Policy - Faculty Page
Health Policy Training Programs at SPH
Petris Center on Healthcare Markets & Consumer Welfare
Stephen Shortell, Ph.D.
Website: National Study of Physician Organizations
BERKELEY PAST GUEST SPEAKERS:
Bruce Bodaken
Dov Chernichovsky, M.A., Ph.D.
Dr. Dov Chernichovsky is the health system adviser to the Israeli Parliament, heads the Health Team at the Taub Centre for Social Policy Studies in Israel, and is a Research Associate with the National Bureau of Economic Research (NBER).
John Ellwood, Ph.D.
Alain C. Enthoven, Ph.D.
Harvey Fineberg, M.D., Ph.D.
Dr. Fineberg served as provost of Harvard University from 1997-2001, following thirteen years as dean of the Harvard School of Public Health.
Susan Desmond-Hellmann, M.D., M.P.H.
Dr. Susan Desmond-Hellmann is responsible for Genentech's Development, Regulatory Affairs, Quality, Compliance, Product Portfolio Management, Alliance Management, Business Development and Pipeline Strategy Support functions. Dr. Hellmann is a member of Genentech's executive committee.
Dr. Hellmann joined Genentech in 1995 as a clinical scientist and she was named executive vice president, Development and Product Operations in 1999, and chief medical officer in 1996. Hellmann is board-certified in Internal Medicine and Medical Oncology and completed her clinical training at UCSF. Prior to joining Genentech, Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb's Pharmaceutical Research Institute. While at Bristol-Myers Squibb, she was the project team leader for Taxol.
John Kitzhaber, M.D.
Kenneth W. Kizer, M.D., M.P.H.
Dr. Kizer previously served as undersecretary for health in the U.S. Department of Veteran Affairs (VA) and is widely credited for the transformation of VA health care since its creation in 1946.
David Lawrence, M.D.
Prior to his positions with Kaiser, Dr. Lawrence was Health Officer and Director of Human Services in Multnomah County, Oregon, and served as the Director of MEDEX at the School of Public Health and Community Medicine at the University of Washington. He also served as an advisor to the Ministry of Health of Chile and as a Peace Corps physician in the Dominican Republic and in Washington, D.C.
Robert M. Pearl, M.D.
Dr. Robert Pearl is responsible for the health care of more than 3.1 million Kaiser Permanente Northern California members. The Permanente Medical Group is composed of approximately 4,400 physicians and 20,000 staff members.
Over the past decade, Dr. Pearl has been a leader in implementing advanced information technology systems across Kaiser Permanente. By combining an integrated delivery system with Internet technology he believes that Kaiser Permanente is uniquely positioned to redefine the practice of medicine as we know it today and develop the health care solutions for the 21st century.
Edward Penhoet, Ph.D.
Kristiana Raube, Ph.D., M.P.H.
Murray Ross, Ph.D.
James Robinson, Ph.D., M.P.H.
Joanne Spetz, Ph.D.
University of California, San Francisco
Web site: Faculty Profile
Gail Wilensky, Ph.D.
Dr. Gail Wilensky is a nationally and internationally recognized expert on a wide range of health policy and financing issues. Her previous position was in the White House, serving as Deputy Assistant to the President for Policy Development, where she advised President George H. W. Bush on health and welfare issues. Dr. Wilensky is very influential in global health care policy circles and was the Administrator of Health Care Financing Administration (HCFA) where she directed the Medicare and Medicaid programs before coming to the White House.
UNIVERSITAT POMPEU FABRA FACULTY & GUEST SPEAKERS
Oriol Amat, M.B.A., Ph.D.
Location: Jaume I, 208, C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.oriolamat.com
Dr. Oriol Amat was President of the European Case Committee (Brussels) from 1988 to 1992; he has been a member of the Board of the College of Economists of Catalunya since 1995 and of the Management Accounting Commission of the Spanish Association for Accounting and Administration since 1994.
At present, Dr. Amat is a member of the Editorial Committees of the Journals Barcelona Management Review, Harvard Deusto, and Finanzas & Contabilidad, and he is a reviewer for Revista Española de Financiación y Contabilidad, European Accounting Review, Barcelona Management Review, European Management Journal, Información Comercial Espaañola and The International Journal of Accounting.
Rafael Bengoa, M.D.
Dr. Rafael Bengoa has worked as a staff member for WHO at several levels and as a consultant for the World Bank. Until recently he was Director of the Department of Management of Noncommunicable Diseases. Before joining WHO, Dr Bengoa was responsible for running health services in the Basque Country Region of Spain and has been responsible for producing several policy reports on health care reform and public health to the Spanish Parliament. His main technical interest is connecting medicine and public health agendas.
Antonio Cabrales, Ph.D.
Location: Department of Economics, Universidad Carlos III de Madrid, Madrid 126, 28903 Getafe, SPAIN
Website: http://www.eco.uc3m.es/acabrales/
Jose Manuel Freire, M.D., M.P.H., M.H.S.A.
Website: http://www.isciii.es
Beatriz González, Ph.D.
Location: Universidad de Las Palmas de GC, Departamento de Métodos Cuantitativos en Economía y Gestión, Campus de Tafira, 35017 Las Palmas de GC
Website: http://www.ulpgc.es/index
Dr. Beatriz González is the former President of the Spanish Health Economics Association. Among many topics she has become an expert on health professionals demographics in Europe, in pharmaceuticals policy and health technology.
Dr. González has been consultant for the WHO, OECD and other international organizations as well as the Spanish Ministry of Health. She has been involved in projects in several developing countries such as Mozambique and Brazil.
Pere Ibern, M.B.A., Ph.D.
Location: Jaume I Building (Campus de la Ciutadella), C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.econ.upf.es/~ibern/
Dr. Pere Ibern has taught health economics and health policy and also has held executive positions in health care organizations. His research activity has been focused on the application of the economics of organization and regulation to the health care sector. He was also Visiting Researcher of the Center for Demographic Studies at Duke University. He has been a consultant for the Human Development Department of The World Bank and has presented testimony to the Spanish Parliamentary Commission on Health Reform.
Guillem López-Casasnovas, Ph.D.
Location: Jaume I Building (Campus de la Ciutadella), C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.upf.edu/cms/pdi/cres/lopez_casasnovas/
Guillem López i Casasnovas is a distinguished member of the Royal College of Economists of Catalonia, a Member of the Royal Academy of Medicine of Catalonia and is associated with the Spanish Academy. As a member of the Advisory Council of the Spanish Ministry of Health and the Catalan Health Department, he has served on commissions on Health Policy, Pharmaceuticals, Health System Reform, Hospital Financing, Ageing and Social Security, and Long Term Care.
He chaired the International Health Economics Association (iHEA) 2005 Conference. In March 2005 he was appointed to the Board of Directors of the Bank of Spain.
Nùria Mas, M.A., Ph.D.
Location: C/ Taquígraf Garriga 95, Barcelona, 08029
Website: http://wwwapp.iese.edu/faculty/
Dr. Mas' research interests focus on the interaction between the public and the private sector, with an emphasis on the health care market. She also analyzes how hospitals and doctors respond to different incentive mechanisms. For example, she studies how different types of health insurance programs affect the incentives of hospitals to adopt new technologies or to provide health care to the uninsured. She also has several projects assessing the effect of different health care systems on the health of their population.
Vicente Ortún, M.Sc., Ph.D.
Location: Jaume I, 291, C/ Ramón Trias Fargas 25-27, 08005 Barcelona
Website: http://www.econ.upf.es/~ortun/
José Luís Pinto Prades, M.Sc., Ph.D.
Senior Lecturer in Health Economics and Applied Political Economics, Universitat Pompeu Fabra and Universidad Pablo de Olavide
Ana Rico, M.A., M.Sc., Ph.D.
Dr. Ana Rico has worked in various positions in educational and research institutions. To mention a few: in the period 1995-1997 she worked as an associate professor of Economics of Organizations, Department of Business Economics, Carlos III University of Madrid. In the period 1999 to 2003 Rico worked as Senior Research Fellow at the European Observatory on Health Care Systems, World Health Organization in Madrid.
Dr. Rico is an expert on consumer surveys.
Marisol Rodríguez, M.Sc., Ph.D.
Location: Parc Científic de Barcelona, Torre D, C/ Baldiri Reixac, 4-6, 3 Floor, B2 08028 Barcelona
Website: http://riscd2.eco.ub.es/~creb/members/marisol.html
Elly Stolk, M.Sc., Ph.D.
Location: Institute for Medical Technology Assessment, Erasmus University Rotterdam, PO Box 1738, Rotterdam, 3000 DR Rotterdam, The Netherlands
Website: http://www.bmg.eur.nl/personal/stolk/
After Dr. Elly Stolk conducted applied cost-effectiveness research for several years, she developed a particular interest in the measurement of individual and social preferences that can be used for informing health care decision-making. This includes both preferences for the quality of life in different health states and preferences regarding equity (fairness) in the distribution of health.
Topics of her recent studies have included equity in health, quality of life measurement, pharmaceutical reimbursement, and the consequences of Alzheimer disease. Dr. Stolk employs empirical methods ranging from questionnaires and trade-off exercises to focus groups and interviews, and draws on theory from economics as well as other social sciences.
BARCELONA PAST GUEST SPEAKERS
Philip C. Berman, Ph.D.
Former Director, European Healthcare Management Association
Dr. Philip Berman is the immediate past Director of European Healthcare Management Association (EHMA). Dr. Berman led the EHMA from 1980-2006.
Dr. Berman has considerable experience of health care systems in Western, Central and Eastern Europe. He has acted both as a World Bank and WHO consultant, advising healthcare management strategies in Poland, Hungary, Romania and Turkey.
Peter Littlejohns, M.D.
Website: http://www.nice.org.uk
Professor Peter Littlejohns was formerly Professor of Public Health at St Georges Hospital Medical School and Director of the Health Care Evaluation Unit. As the Clinical Director of NICE, he is one of 4 Executive Directors and has been in post since the Institute was created in 1999. He has contributed to the establishment of all the guidance development programmes and currently has lead responsibility for Research and Development.
His research interests include most aspects of improving the cost-effectiveness of health care and he was the instigating chief scientist on a European Union BIOMED II funded project to create a critical appraisal instrument for clinical guidelines. His unit was the coordinating centre of a 12 country collaboration which developed the AGREE instrument (Appraising Guidelines, REsearch & Evaluation). He was a founding member and trustee of the AGREE Research Trust. In 1998 he spent a year in South Africa undertaking research into Health Policy funded by the Health Systems Research Trust.
Gillian Morgan, MD
Chief Executive, National Health Service Confederation, England
Previously, Dr. Morgan was chairman from 1996-1997 and president from 1997-1998 of the National Council for the Institute of Health Services Management.
Carles Murillo-Fort, Ph.D.
Professor of Quantitative Economics, Department of Health Sciences, Pompeu Fabra University
Ivan Planas, MSc
Researcher, Center for Health and Economics, Lecturer, Pompeu Fabra University
Jaume Puig-Junoy, Ph.D.
Senior Lecturer in Public Economics, specializing in pharmaceuticals, Universitat Pompeu Fabra
Octavi Quintana, M.D.
Director for Health Research for the European Union
Dr. Quintana is responsible for the 6th Framework Programme for research and technological development. He has served in several positions in the Spanish Health Administration and as president of the European group on Ethics in Science and Technology.
Xavier Sala-i-Martin, Ph.D.
Professor of Economics, Universitat Pompeu Fabra & Columbia University
Jeffrey L. Sturchio, Ph.D.
Vice President, External Affairs, Human Health, Europe, Middle East and Africa, Merck & Co.
Dr. Sturchio is responsible for the development, coordination, and implementation of a range of health policy and communications initiatives for the region. He is also a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria.
Peter Zweifel, Ph.D.
Professor, Socioeconomic Institute of the University of Zurich
Dr. Zweifel is a prominent expert on health insurance.